liothyronine

Studies performed by Kurland, Sonkin, Title, and Morton reported the efficacy of synthetic T3 (liothyronine sodium) in eliminating the symptoms of hypometabolism.

Other Sigmapharm releases include Liothyronine Sodium Tablets, for hypothyroidism, which is the most stable Liothyronine product on the market with a shelf life of 36 months; Adefovir Dipivoxil Tablets, for hepatitis B, which is the first and only generic product equivalent to Hepsera Tablets; and Sodium Phenylbutyrate Powder, for urea cycle disorders, which is the first and only generic product equivalent to Buphenyl Powder.

Its ANDA for liothyronine sodium tablets USP was approved in 5-, 25- and 50-mcg bases.

These include Midamor, 5 mg, in 100 counts, as well as the authorized generic Amiloride HCI tablets USP, 5 mg, in 100 counts; Liothyronine sodium tablets USP, 5 mcg, 25 mcg and 50 mcg (all in 100 counts); Lorazepam oral concentrate USP, 2 mg/mL; and Moexipril HCI/HCTZ tablets, 7.5 mg/12.5 mg, 15 mg/12.5 mg and 15 mg/25 mg (all in 100 counts).

Liothyronine sodium injection, 10 Triostat injection